[Ip-health] Alan Story: A patented Covid-19 vaccine could price out millions | Green World
Michael H Davis
m.davis at csuohio.edu
Thu May 7 10:07:45 PDT 2020
One thing to watch for is whether the patents will bear a legend indicating that the invention is the product of government funding. If they don't, they may be invalid. If they do, it's not a question of whether companies want to share. But with government acquiescence (under Republican or Democratic Administrations), they will probably find themselves having it both ways.
Prof. Mickey Davis
Cleveland State University
2121 Euclid Avenue, LB 234
Cleveland, OH 44115-2214
Cleveland-Marshall College of Law
1801 Euclid Avenue
Law Building, LB 234
Admitted to practice before the United States Patent and Trademark Office, Reg. No. 45,863
From: Ip-health <ip-health-bounces at lists.keionline.org> on behalf of James Love <james.love at keionline.org>
Sent: Thursday, May 7, 2020 11:45 AM
To: Ip-health <ip-health at lists.keionline.org>
Subject: Re: [Ip-health] Alan Story: A patented Covid-19 vaccine could price out millions | Green World
I wanted to comment on this statement by Dick Wilder.
"biotech firms and academic labs will refuse to share their vaccine
technologies and scientific processes"
For a COVID 19 vaccine, governments and donors are providing billions in
direct funding for vaccine development, some through CEPI, and when a
vaccine that works is available, governments will be spending billions more
to buy it. Governments, particularly if they cooperate with each other,
are clearly in a positive to dictate a lot of sharing of IP and know-how,
and if they don't, its a global policy failure.
On Thu, May 7, 2020 at 10:58 AM James Love <james.love at keionline.org> wrote:
> Alan story has a long piece on the patents issues related to vaccines.
> One thing that sticks out is a telling quote from Dick Wilder at CEPI on
> the issue of open licensing. This is pretty significant, given the amount
> of money from government and private donors to CEPI for vaccine development.
> The Costa Rica proposal is “not effective and not necessary”, Richard
> Wilder, general legal counsel of the Coalition for Epidemic Preparedness
> Innovations (CEPI) told Green World last week in an exclusive interview.
> Wilder, who is also CEPI’s director of business development, said
> pharmaceutical companies, biotech firms and academic labs will refuse to
> share their vaccine technologies and scientific processes and there is
> “simply no time now” to do anything different than usual.
> This then becomes a key question of the hour: is the need for a Covid-19
> vaccine, its manufacture and its distribution now so great that “business
> as usual”, as Ellen ‘t Hoen puts it, is a non-starter? And will governments
> require patent holders to share?
> James Love. Knowledge Ecology International
> U.S. Mobile +1.202.361.3040
> U.S. office phone +1.202.332.2670
> http://www.keionline.org <http://www.keionline.org/donate.html>
James Love. Knowledge Ecology International
U.S. Mobile +1.202.361.3040
U.S. office phone +1.202.332.2670
Ip-health mailing list
Ip-health at lists.keionline.org
More information about the Ip-health